GlucoTrack ( (GCTK) ) just unveiled an announcement.
Glucotrack, Inc., a medical technology company specializing in diabetes care, announced its participation in the 2024 Diabetes Technology Meeting with both oral and poster presentations. They will present updated preclinical data for their innovative continuous blood glucose monitor (CBGM), which promises to improve daily management for individuals with diabetes by offering non-intrusive, real-time glucose monitoring without the need for on-body wearables. The company is also developing a long-term implantable CGM system, demonstrating its commitment to advancing diabetes technology and care.
See more data about GCTK stock on TipRanks’ Stock Analysis page.
